ClinicalTrials.gg
CompletedNCT06089993Updated Oct 19, 2023

Impact of Acute Resistance Exercise on Taste Perception and Appetite Response to Plant Protein in Resistance Trained Adults

An interventional study of Exercise and Rest in Appetite, Taste, Altered and Exercise, sponsored by University College Dublin. Completed at 1 site in Ireland. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-19.

Sponsored by University College Dublin · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Aug 2022, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
29
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Some evidence suggests that taste perception might be modulated by physical exercise, with differences observed after aerobic exercise (DOI:10.1093/chemse/23.4.417) and with habitual exercise (DOI:10.3390/nu11010155). However, the effects of resistance exercise on taste perception has not been studied. This knowledge is important as it may impact the acceptability of foods consumed after exercise.

While plant-protein supplement powders are gaining increased popularity, their palatability and, thereby, acceptability may be a shortcoming. This randomised crossover trial aims to investigate (1) the taste perception and acceptability of plant protein supplement powders and (2) whether resistance exercise modulates taste perception and appetite responses to plant protein.

Read the detailed description

Phase 1 (part 1): A randomised crossover trial, involving 15-20 adult men (aged 18-40 years old). Two conditions (resistance exercise or rest) will be undertaken in randomised order.

Participants will be required to attend three tests visits. The first visit will last approximately 2 hours and involves signing informed consent, body composition assessment (BodPod), strength tests (3-Repetition Maximum) and completion of questionnaires.

The second and third visits are the experimental test visits (exercise or rest) and will last approximately 4 hours each. Individuals will arrive at the laboratory two hours after consuming a standardized breakfast.

Participants will be provided with eight food-grade samples and asked to complete a battery of questionnaires to evaluate taste perception and liking (visual analogue scales (VAS), generalised labelled magnitude scale (gLMS), 9-point Likert scale). The eight samples are: (1) sucrose (2) umami (3) soy protein (4) pea protein (5) hemp protein (6) brown rice (7) whey protein and (8) apple juice. Each sample will be served as a 20-mL-solution. Except for sucrose and umami (in water), the protein-based samples will be served in low sugar apple juice. Subjects will taste the samples in a "sip-and-spit" manner. Each solution will be designated by a 3-digit number and they will be provided in a randomized order.

Participants will then undergo approximately 1 hour of rest (control) or resistance exercise conditions, after which they will repeat an identical tasting session of the 8 samples.

The resistance exercise will be composed of the 4 exercises, that will be performed at a high-to-medium intensity (75% of the maximum calculated), intensity represented by 10 estimated repetitions. Four sets of each exercise will be assisted by the investigator.

Phase 1 (part 2): The second part of each test visit (exercise or rest) involves the participant consuming a soy protein drink (30g soy protein powder, according to most of the manufacturer's recommendation) solubilized in 200ml low-sugar apple juice (to increase palatability). After an hour of rest, the participant will then be served an ad libitum lunch meal (pasta bake with tomato sauce and cheese, strawberry yogurt and water). Appetite will be assessed both during rest and after the lunch meal via VAS.

Saliva samples will also be collected at three time-points during the test visit to provide insight into potential mechanisms contributing to alterations in taste perception and appetite.

Phase 2: Part 1 is extended to 15-20 adult female participants (18-40 years old) to provide insight into any potential sex differences in findings. The eight samples tested are identical except brown rice protein is replaced with clear protein isolate (a form of hydrolysed pea protein).

02

Conditions studied

  • Appetite
  • Taste, Altered
  • Exercise

Keywords

  • protein
  • plant protein
  • soy protein
  • hemp protein
  • brown rice protein
  • pea protein
  • whey protein
  • taste perception
  • taste
  • appetite
  • sensory perception
  • Visual Analogue Scale
  • Likert Scale
  • strength training
  • resistance training
03

In context

Dysgeusia

52 studies on the registry are indexed under Dysgeusia; 12 are open to participants now.

This study's enrollment of 29 is below the median of 49 across 28 interventional studies indexed under Dysgeusia.

Browse Dysgeusia studies →

Lead sponsor

University College Dublin is the lead sponsor of 113 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Phase 1: Adult males; Phase 2: Adult females
  • Aged between 18 and 40 y.o.)
  • Physically active in accordance with IPAQ
  • Lifting weights, at least, once a week
  • Healthy
  • Non-smokers
  • between 18 and 30

Exclusion criteria

Exclusion Criteria:

  • Phase 1: Females; Phase 2: Males
  • Subjects younger than 18 or older than 40 y.o.
  • lower than 18 and higher than 30
  • Insufficiently active individuals
  • Physical active individuals that do not perform a regular strength training
  • Having any condition health-related that could preclude both their participation in physical testing and a bout of resistance training
  • Taking medications known to impact taste and/or appetite
  • Medical condition known to impact taste and/or appetite
  • Medical condition linked to cognitive impairment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
29 participants (actual)

Study arms

  • Experimental
    Exercise

    Resistance exercise involves 4 exercises (bench pull, bench press, leg extension and unilateral leg press), that are performed at 75% of maximum, determined from 3-RM test.

    Other: Exercise

  • Experimental
    Rest

    One hour rest.

    Other: Rest

Interventions

  • OtherExercise

    The total volume of exercise is 40 repetitions of each of the 4 exercises. The participant is instructed to perform a maximum of 10 repetitions each set, with 1'30'' rest between sets and between exercises. The researcher provides instructions and verbal encouragement. The total duration of the exercise bout is between 1 hour and 1 hour and 15 minutes. Part 1: Before and after the exercise condition the participant is sampling 8 different samples: (1) sucrose (2) umami (3) soy protein (4) pea protein (5) hemp protein (6) brown rice (7) whey protein and (8) apple juice. All protein sources are 3 grams dissolved in 20ml apple juice. Sucrose is 1.66g in 20ml water and umami tastant is 0.09g in 20ml water. Part 2: a 30g soy protein bolus in 200ml apple juice is given to the participant. After 1 hour energy intake is assessed with an ad libitum lunch meal.

  • OtherRest

    The participant remains in sedentary activities such as reading or using a laptop. Part 1: Before and after the rest condition the participant is sampling 8 different samples: (1) sucrose (2) umami (3) soy protein (4) pea protein (5) hemp protein (6) brown rice (7) whey protein and (8) apple juice. All protein sources are 3 grams dissolved in 20ml apple juice. Sucrose is 1.66g in 20ml water and umami tastant is 0.09g in 20ml water. Part 2: a 30g soy protein bolus in 200ml apple juice is given to the participant. After 1 hour energy intake is assessed with an ad libitum lunch meal.

06

What researchers measure

Primary outcomes

  1. Part 1: Change in Taste Intensity

    Taste intensity from Generalised Labelled Magnitude Scale (gLMS) Validated 200 millimetre scales will be used to assess intensity of the taste of each sample. This scale has anchors located at each end of the scale and along the scale (barely detectable, weak, moderate, strong, very strong, strongest imaginable). On the bottom end of the scale, the extreme negative response (0 mm) is represented, while the top end (200 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.

    Time frame: 2 hours: (1) baseline sampling session, (2) post-intervention sampling session (i.e. after 1 hour resistance training or rest).

  2. Part 1: Change in Liking of the samples

    9-point Likert Scale to rate overall liking of each sample, from 0 (dislike extremely) to 9 (like extremely).

    Time frame: 2 hours: (1) baseline sampling session, (2) post-intervention sampling session (i.e. after 1 hour resistance training or rest). Change scores will be compared between exercise and rest condition.

  3. Part 2: Change in Appetite - Composite Appetite Score

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to assess appetite, at six (6) set time points throughout the experimental visit. This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Composite Appetite Score derived from aspects such as hunger, fullness, desire to eat and prospective food consumption will be calculated.

    Time frame: 3.5 hours: (1) at participant arrival, (2) after exercise or resting condition (3) immediately after the protein bolus (4) 30 minutes after the protein bolus (5) 60 minutes after the protein bolus (6) after the lunch meal

  4. Part 2: Energy Intake

    Energy intake measurement. Participants will be given a standardised fixed breakfast to be eaten at home 2 hours prior the testing visit. At the end of the testing visit participants will be served with ad libitum lunch meal in the laboratory. Lunch EI (kilocalories) will be measured objectively, by weighing foods before and after consumption and calculating energy intake based on their nutritional data. EI will be compared between exercise and rest conditions

    Time frame: Day 2 and Day 3

Secondary outcomes

  1. Part 2: changes in cortisol

    Saliva sample will be collected by passive drooling three (3) times.

    Time frame: 3 hours: (1) immediately after participant arrival, (2) after exercise or rest, (3) 1 hour after exercise or rest (i.e. immediately before the lunch meal)

  2. Part 2: changes in testosterone

    Saliva sample will be collected by passive drooling three (3) times.

    Time frame: 3 hours: (1) immediately after participant arrival, (2) after exercise or rest, (3) 1 hour after exercise or rest (i.e. immediately before the lunch meal)

  3. Part 2: Palatability - Pleasantness

    100 millimetre Visual Analogue Scales (VAS) will be used immediately after the protein bolus and the lunch meal. This VAS has anchors located at each end of the scale. On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Data will be compared between exercise and rest conditions.

    Time frame: Day 2 and Day 3

  4. Part 2: Palatability - Filling

    100 millimetre Visual Analogue Scales (VAS) will be used immediately after the protein bolus and the lunch meal. This VAS has anchors located at each end of the scale. On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Data will be compared between exercise and rest conditions.

    Time frame: Day 2 and Day 3

  5. Part 2: Palatability - Satisfaction

    100 millimetre Visual Analogue Scales (VAS) will be used immediately after the protein bolus and the lunch meal. This VAS has anchors located at each end of the scale. On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Data will be compared between exercise and rest conditions.

    Time frame: Day 2 and Day 3

  6. Part 2: Palatability - Taste

    100 millimetre Visual Analogue Scales (VAS) will be used immediately after the protein bolus and the lunch meal. This VAS has anchors located at each end of the scale. On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Data will be compared between exercise and rest conditions.

    Time frame: Day 2 and Day 3

  7. Part 2: Palatability - Sweet

    100 millimetre Visual Analogue Scales (VAS) will be used immediately after the protein bolus and the lunch meal. This VAS has anchors located at each end of the scale. On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Data will be compared between exercise and rest conditions.

    Time frame: Day 2 and Day 3

  8. Part 2: Palatability - Savoury

    100 millimetre Visual Analogue Scales (VAS) will be used immediately after the protein bolus and the lunch meal. This VAS has anchors located at each end of the scale. On the left end of the scale (0 mm), the extreme negative response is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Data will be compared between exercise and rest conditions.

    Time frame: Day 2 and Day 3

  9. Part 2: Changes in Hunger

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to estimate changes in appetite, at six (6) set time points throughout the experimental visit. This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Data will be compared between exercise and rest conditions.

    Time frame: 3.5 hours: (1) at participant arrival, (2) after exercise or resting condition (3) immediately after the protein bolus (4) 30 minutes after the protein bolus (5) 60 minutes after the protein bolus (6) after lunch. Mixed model ANOVA will be used.

  10. Part 2: Changes in Fullness

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to estimate changes in appetite, at six (6) set time points throughout the experimental visit. This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Data will be compared between exercise and rest conditions.

    Time frame: 3.5 hours: (1) at participant arrival, (2) after exercise or resting condition (3) immediately after the protein bolus (4) 30 minutes after the protein bolus (5) 60 minutes after the protein bolus (6) after lunch. Mixed model ANOVA will be used.

  11. Part 2: Changes in Desire to Eat

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to estimate changes in appetite, at six (6) set time points throughout the experimental visit. This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Data will be compared between exercise and rest conditions.

    Time frame: 3.5 hours: (1) at participant arrival, (2) after exercise or resting condition (3) immediately after the protein bolus (4) 30 minutes after the protein bolus (5) 60 minutes after the protein bolus (6) after lunch. Mixed model ANOVA will be used.

  12. Part 2: Changes in Prospective Food Consumption

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to estimate changes in appetite, at six (6) set time points throughout the experimental visit. This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Data will be compared between exercise and rest conditions.

    Time frame: 3.5 hours: (1) at participant arrival, (2) after exercise or resting condition (3) immediately after the protein bolus (4) 30 minutes after the protein bolus (5) 60 minutes after the protein bolus (6) after lunch. Mixed model ANOVA will be used.

  13. Part 1: Changes in Sensory Perception - Visual Appeal

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to assess sensory perception during two sampling session (8 times each sampling session). This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends. Change scores will be compared between exercise and rest conditions.

    Time frame: 2 hours: (1) baseline sampling session, (2) post-intervention sampling session (i.e. after 1 hour resistance training or rest)

  14. Part 1: Changes in Sensory Perception - Smell

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to assess sensory perception during two sampling session (8 times each sampling session). This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Change scores will be compared between exercise and rest conditions.

    Time frame: 2 hours: (1) baseline sampling session, (2) post-intervention sampling session (i.e. after 1 hour resistance training or rest)

  15. Part 1: Changes in Sensory Perception - Taste

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to assess sensory perception during two sampling session (8 times each sampling session). This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Change scores will be compared between exercise and rest conditions.

    Time frame: 2 hours: (1) baseline sampling session, (2) post-intervention sampling session (i.e. after 1 hour resistance training or rest)

  16. Part 1: changes in Sensory Perception - Aftertaste

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to assess sensory perception during two sampling session (8 times each sampling session). This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Change scores will be compared between exercise and rest conditions.

    Time frame: 2 hours: (1) baseline sampling session, (2) post-intervention sampling session (i.e. after 1 hour resistance training or rest)

  17. Part 1: Changes in Sensory Perception - Palatability

    Validated 100 millimetre Visual Analogue Scales (VAS) will be used to assess sensory perception during two sampling session (8 times each sampling session). This VAS has anchors located at each end of the scale. On the left end of the scale, the extreme negative response (0 mm) is represented, while the right end (100 mm) represents the positive response. Participants mark along the line where it most represents their subjective perception between both ends.Change scores will be compared between exercise and rest conditions.

    Time frame: 2 hours: (1) baseline sampling session, (2) post-intervention sampling session (i.e. after 1 hour resistance training or rest)

07

Study locations

1 site
  • University College Dublin
    Dublin, Ireland
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2022 to primary completion in May 2023, 9 months.

Of 18 interventional studies with no phase under Dysgeusia, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 16. This study's 9 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2023
First posted
Oct 19, 2023
StartActual
Aug 8, 2022
Primary completionActual
May 19, 2023
CompletionActual
May 19, 2023
Last update
Oct 19, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06089993
Responsible party
Katy Horner (Lecturer in Sport and Exercise Science, University College Dublin) — Principal investigator
First posted
Oct 19, 2023
Start date
Aug 8, 2022
Primary completion
May 19, 2023
Completion
May 19, 2023
Last update
Oct 19, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion